CPDU Financials Monday, July 14, 2014 12:36:49 PM
Post# of 3
China Pediatric Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 3,726 14,168 27,415 24,472
Cost of Revenue 2,435 8,895 15,082 11,503
Gross Profit 1,291 5,273 12,333 12,969
Operating Expenses
Research and Development - - 1,856 -
Sales, General and Admin. 3,419 8,665 20,408 6,192
Non-Recurring Items (1,292) 5,760 2,772 -
Other - - - -
Operating Income (836) (9,152) (12,704) 6,776
Income From Continuing Operations
Add'l Income/Expense Items 58 - 5,748 243
Earnings Before Interest and Tax (756) (9,152) (6,967) 7,020
Interest Expense - - - 24
Earnings Before Tax (756) (9,152) (6,967) 6,996
Income Tax - - - 1,024
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (756) (9,152) (6,967) 5,972
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (756) (9,152) (6,967) 5,972
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (756) (9,152) (6,967) 5,972